Xcel Infusion Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 17 Days
- Last Filing with ROC 31 Mar 2020
About Xcel Infusion
Xcel Infusion Private Limited (XIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 February 2019 (Six years 17 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Avinash Verma and Satya Prakash serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999HR2019PTC078420
- Company No.
078420
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2019
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Xcel Infusion Private Limited offer?
Xcel Infusion Private Limited offers a wide range of products and services, including Data Entry & Data Processing Service, Data Conversion Services, BPO Operations and Services, BPO Services, Copyright & Trademark, Patent Registration Services, Computer & Mobile Apps Development, Mobile Application Development, Data Digitization.
Who are the key members and board of directors at Xcel Infusion?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Verma  | Director | 09-Feb-2019 | Current |
| Satya Prakash | Director | 22-Jun-2019 | Current |
Financial Performance of Xcel Infusion.
Xcel Infusion Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Xcel Infusion?
In 2020, Xcel Infusion had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xcel Infusion?
Unlock and access historical data on people associated with Xcel Infusion, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xcel Infusion, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xcel Infusion's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
